Edition:
United States

Bioporto A/S (BIOPOR.CO)

BIOPOR.CO on Copenhagen Stock Exchange

1.68DKK
10:59am EST
Change (% chg)

kr.-0.05 (-2.89%)
Prev Close
kr.1.73
Open
kr.1.73
Day's High
kr.1.75
Day's Low
kr.1.67
Volume
416,383
Avg. Vol
328,964
52-wk High
kr.5.40
52-wk Low
kr.1.40

Select another date:

Mon, Nov 14 2016

BRIEF-BioPorto private placement fully subscribed

* Board has decided to issue 12.9 million new shares against payment of 1.69 Danish crown per share

BRIEF-BioPorto: Private placement of up to DKK 21.8 million

* Said on Friday had initiated cash issue, private placement, of up to 12.9 million new shares to selected shareholders, institutional and financial investors

BRIEF-EPO approves BioPorto's NGAL cutoff patent for issue

* European Patent Office (EPO) announced, that BioPorto's NGAL Cutoff patent has been approved for issue

BRIEF-BioPorto Q3 EBIT loss widens to DKK 7.1 million, outlook cut

* Q3 revenue 4.6 million Danish crowns ($687,480) versus 4.7 million crowns year ago

BRIEF-BioPorto files pre-sub application for NGAL test to FDA

* Maintains expectation that approval can be obtained by mid-2018

BRIEF-BioPorto Q2 EBIT loss increases to DKK 7.7 mln

* Q2 revenue 4.7 million Danish crowns ($703,382.22) versus 5.8 million crowns year ago

BRIEF-BioPorto to reapply for FDA approval of NGAL Test

* Financial outlook for 2016 is maintained Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: